BioMeta (Shanghai) Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
150
- Latest Deal Type
-
Series A1
- Investors
-
4
BioMeta (Shanghai) General Information
Description
Developer of preclinical drugs designed for the biomedical industry. The company offers preclinical drug discovery, target verification, protein production, antibody production, in vitro drug testing, and cell level testing, enabling pharmaceutical companies and biotech startups to advance from concept to clinical readiness.
Contact Information
Website
www.biometas.cnCorporate Office
- 2nd Floor, Building 5
- Number 334 Edison Road, China Pilot Free Trade Zone
- Shanghai, 201203
- China
Corporate Office
- 2nd Floor, Building 5
- Number 334 Edison Road, China Pilot Free Trade Zone
- Shanghai, 201203
- China
BioMeta (Shanghai) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 20-Jan-2026 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 18-Sep-2024 | Completed | Generating Revenue |
BioMeta (Shanghai) Signals
BioMeta (Shanghai) Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adtech Advanced Technologies | Corporation | Minority | ||
| Hefei Industry Investment Group | Venture Capital | Minority | ||
| Huagai Capital | Venture Capital | Minority | ||
| PharmaResources | Corporation | Minority |
BioMeta (Shanghai) Investments & Acquisitions (2)
BioMeta (Shanghai)’s most recent deal was a Later Stage VC with Drug Farm for . The deal was made on 13-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Drug Farm | 13-Jul-2026 | Later Stage VC | Drug Discovery | ||
| ZSHK Lab | 14-Apr-2026 | Merger/Acquisition | Laboratory Services (Healthcare) |
BioMeta (Shanghai) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ZSHK Lab | Hong Kong, Hong Kong | 2019 |
BioMeta (Shanghai) FAQs
-
When was BioMeta (Shanghai) founded?
BioMeta (Shanghai) was founded in 2022.
-
Where is BioMeta (Shanghai) headquartered?
BioMeta (Shanghai) is headquartered in Shanghai, China.
-
What is the size of BioMeta (Shanghai)?
BioMeta (Shanghai) has 150 total employees.
-
What industry is BioMeta (Shanghai) in?
BioMeta (Shanghai)’s primary industry is Drug Discovery.
-
Is BioMeta (Shanghai) a private or public company?
BioMeta (Shanghai) is a Private company.
-
What is BioMeta (Shanghai)’s current revenue?
The current revenue for BioMeta (Shanghai) is .
-
Who are BioMeta (Shanghai)’s investors?
Adtech Advanced Technologies, Hefei Industry Investment Group, Huagai Capital, and PharmaResources have invested in BioMeta (Shanghai).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process